Literature DB >> 22641202

Traversing the genomic landscape of prostate cancer from diagnosis to death.

Haley Hieronymus, Charles L Sawyers.   

Abstract

The clinical spectrum of prostate cancer ranges from curable, local disease to widely metastatic, lethal cancer. Two new prostate cancer genome studies provide the first glimpse at both ends of this spectrum.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22641202     DOI: 10.1038/ng.2301

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  13 in total

1.  Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.

Authors:  Jack Cuzick; Gregory P Swanson; Gabrielle Fisher; Arthur R Brothman; Daniel M Berney; Julia E Reid; David Mesher; V O Speights; Elzbieta Stankiewicz; Christopher S Foster; Henrik Møller; Peter Scardino; Jorja D Warren; Jimmy Park; Adib Younus; Darl D Flake; Susanne Wagner; Alexander Gutin; Jerry S Lanchbury; Steven Stone
Journal:  Lancet Oncol       Date:  2011-03       Impact factor: 41.316

2.  Integrative genomic profiling of human prostate cancer.

Authors:  Barry S Taylor; Nikolaus Schultz; Haley Hieronymus; Anuradha Gopalan; Yonghong Xiao; Brett S Carver; Vivek K Arora; Poorvi Kaushik; Ethan Cerami; Boris Reva; Yevgeniy Antipin; Nicholas Mitsiades; Thomas Landers; Igor Dolgalev; John E Major; Manda Wilson; Nicholas D Socci; Alex E Lash; Adriana Heguy; James A Eastham; Howard I Scher; Victor E Reuter; Peter T Scardino; Chris Sander; Charles L Sawyers; William L Gerald
Journal:  Cancer Cell       Date:  2010-06-24       Impact factor: 31.743

3.  Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.

Authors:  Christopher E Barbieri; Sylvan C Baca; Michael S Lawrence; Francesca Demichelis; Mirjam Blattner; Jean-Philippe Theurillat; Thomas A White; Petar Stojanov; Eliezer Van Allen; Nicolas Stransky; Elizabeth Nickerson; Sung-Suk Chae; Gunther Boysen; Daniel Auclair; Robert C Onofrio; Kyung Park; Naoki Kitabayashi; Theresa Y MacDonald; Karen Sheikh; Terry Vuong; Candace Guiducci; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Gordon Saksena; Douglas Voet; Wasay M Hussain; Alex H Ramos; Wendy Winckler; Michelle C Redman; Kristin Ardlie; Ashutosh K Tewari; Juan Miguel Mosquera; Niels Rupp; Peter J Wild; Holger Moch; Colm Morrissey; Peter S Nelson; Philip W Kantoff; Stacey B Gabriel; Todd R Golub; Matthew Meyerson; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nat Genet       Date:  2012-05-20       Impact factor: 38.330

Review 4.  Molecular genetics of prostate cancer: new prospects for old challenges.

Authors:  Michael M Shen; Cory Abate-Shen
Journal:  Genes Dev       Date:  2010-09-15       Impact factor: 11.361

5.  Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors.

Authors:  Christiane M Robbins; Waibov A Tembe; Angela Baker; Shripad Sinari; Tracy Y Moses; Stephen Beckstrom-Sternberg; James Beckstrom-Sternberg; Michael Barrett; James Long; Arul Chinnaiyan; James Lowey; Edward Suh; John V Pearson; David W Craig; David B Agus; Kenneth J Pienta; John D Carpten
Journal:  Genome Res       Date:  2010-12-08       Impact factor: 9.043

6.  Distinct genomic aberrations associated with ERG rearranged prostate cancer.

Authors:  Francesca Demichelis; Sunita R Setlur; Rameen Beroukhim; Sven Perner; Jan O Korbel; Christopher J Lafargue; Dorothee Pflueger; Cara Pina; Matthias D Hofer; Andrea Sboner; Maria A Svensson; David S Rickman; Alex Urban; Michael Snyder; Matthew Meyerson; Charles Lee; Mark B Gerstein; Rainer Kuefer; Mark A Rubin
Journal:  Genes Chromosomes Cancer       Date:  2009-04       Impact factor: 5.006

7.  Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases.

Authors:  Manabu Furukawa; Yizhou Joseph He; Christoph Borchers; Yue Xiong
Journal:  Nat Cell Biol       Date:  2003-10-05       Impact factor: 28.824

8.  The genomic complexity of primary human prostate cancer.

Authors:  Michael F Berger; Michael S Lawrence; Francesca Demichelis; Yotam Drier; Kristian Cibulskis; Andrey Y Sivachenko; Andrea Sboner; Raquel Esgueva; Dorothee Pflueger; Carrie Sougnez; Robert Onofrio; Scott L Carter; Kyung Park; Lukas Habegger; Lauren Ambrogio; Timothy Fennell; Melissa Parkin; Gordon Saksena; Douglas Voet; Alex H Ramos; Trevor J Pugh; Jane Wilkinson; Sheila Fisher; Wendy Winckler; Scott Mahan; Kristin Ardlie; Jennifer Baldwin; Jonathan W Simons; Naoki Kitabayashi; Theresa Y MacDonald; Philip W Kantoff; Lynda Chin; Stacey B Gabriel; Mark B Gerstein; Todd R Golub; Matthew Meyerson; Ashutosh Tewari; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

9.  Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.

Authors:  J Cuzick; D M Berney; G Fisher; D Mesher; H Møller; J E Reid; M Perry; J Park; A Younus; A Gutin; C S Foster; P Scardino; J S Lanchbury; S Stone
Journal:  Br J Cancer       Date:  2012-02-23       Impact factor: 7.640

10.  The mutational landscape of lethal castration-resistant prostate cancer.

Authors:  Catherine S Grasso; Yi-Mi Wu; Dan R Robinson; Xuhong Cao; Saravana M Dhanasekaran; Amjad P Khan; Michael J Quist; Xiaojun Jing; Robert J Lonigro; J Chad Brenner; Irfan A Asangani; Bushra Ateeq; Sang Y Chun; Javed Siddiqui; Lee Sam; Matt Anstett; Rohit Mehra; John R Prensner; Nallasivam Palanisamy; Gregory A Ryslik; Fabio Vandin; Benjamin J Raphael; Lakshmi P Kunju; Daniel R Rhodes; Kenneth J Pienta; Arul M Chinnaiyan; Scott A Tomlins
Journal:  Nature       Date:  2012-07-12       Impact factor: 49.962

View more
  12 in total

Review 1.  Revisiting the role of Wnt/β-catenin signaling in prostate cancer.

Authors:  Jeffrey A Schneider; Susan K Logan
Journal:  Mol Cell Endocrinol       Date:  2017-02-09       Impact factor: 4.102

2.  GLI3 Is Stabilized by SPOP Mutations and Promotes Castration Resistance via Functional Cooperation with Androgen Receptor in Prostate Cancer.

Authors:  Marieke Burleson; Janice J Deng; Tai Qin; Thu Minh Duong; Yuqian Yan; Xiang Gu; Debodipta Das; Acarizia Easley; Michael A Liss; P Renee Yew; Roble Bedolla; Addanki Pratap Kumar; Tim Hui-Ming Huang; Yi Zou; Yidong Chen; Chun-Liang Chen; Haojie Huang; Lu-Zhe Sun; Thomas G Boyer
Journal:  Mol Cancer Res       Date:  2021-10-05       Impact factor: 6.333

Review 3.  The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencing.

Authors:  Alexander W Wyatt; Fan Mo; Yuzhuo Wang; Colin C Collins
Journal:  Asian J Androl       Date:  2013-03-18       Impact factor: 3.285

4.  Long noncoding RNA-mediated activation of androgen receptor in prostate cancer.

Authors:  Gyorgy Petrovics; Shiv Srivastava
Journal:  Asian J Androl       Date:  2014 May-Jun       Impact factor: 3.285

5.  Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between White (non-Hispanic) and African-American groups.

Authors:  Naif Zaman; Paresa N Giannopoulos; Shafinaz Chowdhury; Eric Bonneil; Pierre Thibault; Edwin Wang; Mark Trifiro; Miltiadis Paliouras
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

Review 6.  Microtubule-associated proteins (MAPs) in microtubule cytoskeletal dynamics and spermatogenesis.

Authors:  Lingling Wang; Ming Yan; Chris K C Wong; Renshan Ge; Xiaolong Wu; Fei Sun; C Yan Cheng
Journal:  Histol Histopathol       Date:  2020-11-11       Impact factor: 2.303

7.  Biological and clinical significance of androgens and androgen receptor in prostate cancer.

Authors:  Shahriar Koochekpour
Journal:  Int J Biol Sci       Date:  2014-06-10       Impact factor: 6.580

8.  Beyond the androgen receptor: new approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer Meeting.

Authors:  Kenneth J Pienta; Guneet Walia; Jonathan W Simons; Howard R Soule
Journal:  Prostate       Date:  2014-02       Impact factor: 4.104

9.  Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells.

Authors:  Eugine Lee; Susan Ha; Susan K Logan
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

Review 10.  Genetics and biology of prostate cancer.

Authors:  Guocan Wang; Di Zhao; Denise J Spring; Ronald A DePinho
Journal:  Genes Dev       Date:  2018-09-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.